Abstract
Maternal intravenous administration of thyrotropin releasing hormone (TRH) is associated with rapid elevations of blood pressure, potentially causative of cerebrovascular accidents. We report a case in which peak blood pressure of 220/120 mm Hg was attained from a baseline of 132/80 mm Hg following TRH administration in a preeclamptic patient.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 5-6 |
| Number of pages | 2 |
| Journal | American Journal of Perinatology |
| Volume | 14 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 1997 |
| Externally published | Yes |
Keywords
- Preeclampsia
- blood pressure
- thyrotropin releasing hormone (TRH)
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Obstetrics and Gynecology
Fingerprint
Dive into the research topics of 'Is maternal thyrotropin releasing hormone administration safe in the pregnant woman with preeclampsia?'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS